Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05814822 · ClinicalTrials.gov registry record · NA

Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use

A NA study of Insomnia, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05814822: Recruiting NA study of Insomnia, sponsored by University of Michigan.

NCT05814822 is a NA study of Insomnia that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 200 participants, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05814822, a NA study of Insomnia, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study will compare the efficacy of telemedicine-delivered cognitive behavioral therapy for insomnia tailored for people using cannabis for sleep (CBTi-CB-TM) to telemedicine-delivered sleep hygiene education (SHE-TM) on sleep, cannabis use, and daytime functioning. We will also evaluate the effects of CBTi-CB-TM on fundamental sleep regulatory system - homeostatic sleep drive - and its association with clinical outcomes.

Primary Outcome

Changes in frequency of cannabis use will be evaluated over the past 30 days using the Timeline Followback, widely considered the "gold standard" tool for assessing daily substance use. It will be used to measure the frequency of use of THC-containing cannabis products used across all modalities guided by pictorial aids. Participants are asked to specify motivations behind cannabis use, including recreation, medicinal use, sleep aid, or other reasons. We will collect data on alcohol and other su

Conditions Studied

Insomnia

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM)
  • BEHAVIORAL Sleep Hygiene Education (SHE-TM)

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-06-01
Est. Completion 2027-08-31
Phase NA
University of Michigan

1,327 total trials

What NCT05814822 shows while recruiting

NCT05814822 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (18% higher).

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM) is the first listed.

NCT05814822 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05814822 about?

NCT05814822 is a clinical study titled "Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use". This study will compare the efficacy of telemedicine-delivered cognitive behavioral therapy for insomnia tailored for people using cannabis for sleep (CBTi-CB-TM) to telemedicine-delivered sleep hygiene education (SHE-TM) on sleep, cannabis use, and daytime functioning. We will also evaluate the eff...

What is the current status of trial NCT05814822?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-06-01. Estimated completion is 2027-08-31.

What conditions does trial NCT05814822 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT05814822?

The interventions under investigation include: Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM) (BEHAVIORAL), Sleep Hygiene Education (SHE-TM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05814822?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05814822 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05814822's enrollment target sits among peer trials

200 34th of 151 higher than 116 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05814822

Source: ClinicalTrials.gov NCT05814822, the US trial registry maintained by the National Library of Medicine. NCT05814822 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.